
Stryker (SYK) Stock Forecast & Price Target
Stryker (SYK) Analyst Ratings
Bulls say
Stryker is expected to achieve a notable operating margin improvement of approximately 210 basis points for the years 2024 and 2025, driven by its Operational Excellence initiatives and a robust order book. The company's ongoing focus on expanding into high-growth markets has positively influenced its weighted average market growth rate, indicating strong revenue momentum. Additionally, Stryker projects an increase in EPS from $16.50 in the previous year to $16.69 by 2027, reflecting confidence in sustained financial performance.
Bears say
The negative outlook on Stryker's stock stems from several fundamental challenges, including disruptions caused by recent acquisitions and a slowdown in Mako utilization amid increasing competition, which may adversely affect revenue and operating margins. Furthermore, the company faces risks associated with a declining environment for elective procedures, constrained hospital capital spending, and potential earnings dilution from acquisitions that could hinder overall growth performance. With projections indicating organic revenue growth slowing to 8% or less and expectations of limited margin expansion, Stryker may struggle to meet its long-term earnings growth targets.
This aggregate rating is based on analysts' research of Stryker and is not a guaranteed prediction by Public.com or investment advice.
Stryker (SYK) Analyst Forecast & Price Prediction
Start investing in Stryker (SYK)
Order type
Buy in
Order amount
Est. shares
0 shares